Cargando…
LT4 and Slow Release T3 Combination: Optimum Therapy for Hypothyroidism?
CONTEXT: Levothyroxine (LT4) is recommended as replacement therapy for thyroid hormone deficiency. However, some hypothyroid patients receiving LT4 therapy do not feel as well as healthy subjects. This article aimed to review current knowledge regarding LT4 monotherapy versus LT4+LT3 combination the...
Autores principales: | Azizi, Fereidoun, Amouzegar, Atieh, Mehran, Ladan, Abdi, Hengameh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322563/ https://www.ncbi.nlm.nih.gov/pubmed/32636887 http://dx.doi.org/10.5812/ijem.100870 |
Ejemplares similares
-
Tehran Thyroid Study (TTS)
por: Amouzegar, Atieh, et al.
Publicado: (2018) -
Insulin Monotherapy Versus Insulin Combined with Other Glucose-Lowering Agents in Type 2 Diabetes: A Narrative Review
por: Abdi, Hengameh, et al.
Publicado: (2018) -
Pharmacodynamic and pharmacokinetic properties of the combined preparation of levothyroxine plus sustained- release liothyronine; a randomized controlled clinical trial
por: Mehran, Ladan, et al.
Publicado: (2023) -
Efficacy and Safety of Long-Term Methimazole versus Radioactive Iodine in the Treatment of Toxic Multinodular Goiter
por: Azizi, Fereidoun, et al.
Publicado: (2022) -
Antithyroid Drugs
por: Abdi, Hengameh, et al.
Publicado: (2019)